These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10578119)

  • 1. The development of live attenuated cold-adapted influenza virus vaccine for humans.
    Maassab HF; Bryant ML
    Rev Med Virol; 1999; 9(4):237-44. PubMed ID: 10578119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.
    White CL; Chiem K; Perez DR; Santos J; Cardenas Garcia S; Nogales A; Martínez-Sobrido L
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34208979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.
    Murphy BR; Coelingh K
    Viral Immunol; 2002; 15(2):295-323. PubMed ID: 12081014
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist).
    Chen Z; Aspelund A; Kemble G; Jin H
    Virology; 2006 Feb; 345(2):416-23. PubMed ID: 16289204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers.
    Clements ML; Snyder MH; Sears SD; Maassab HF; Murphy BR
    J Infect Dis; 1990 May; 161(5):869-77. PubMed ID: 2324538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and identification of a new Vero cell-based live attenuated influenza B vaccine by a modified classical reassortment method.
    Yang F; Ma L; Zhou J; Wu Y; Gao J; Song S; Geng X; Guo Q; Li Z; Li W; Liao G; Li Y
    Expert Rev Vaccines; 2017 Aug; 16(8):855-863. PubMed ID: 28581345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of live attenuated cold-adapted influenza B/Yamagata/16/88 reassortant virus vaccine in healthy adults.
    Treanor JJ; Betts RF
    J Infect Dis; 1993 Aug; 168(2):455-9. PubMed ID: 8335984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
    Garmashova LM; Polezhaev FI; Aleksandrova GI
    Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live cold-adapted influenza A vaccine produced in Vero cell line.
    Romanova J; Katinger D; Ferko B; Vcelar B; Sereinig S; Kuznetsov O; Stukova M; Erofeeva M; Kiselev O; Katinger H; Egorov A
    Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/Ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses.
    Obrosova-Serova NP; Slepushkin AN; Kendal AP; Harmon MW; Burtseva EI; Bebesheva NI; Beljaev AL; Lonskaja NI; Medvedeva TE; Egorov AY
    Vaccine; 1990 Feb; 8(1):57-60. PubMed ID: 2180233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.
    Krutikova EV; Stepanova EA; Wong PF; Kiseleva IV; Grigor'eva EP; Rudenko LG
    Bull Exp Biol Med; 2020 Mar; 168(5):669-672. PubMed ID: 32248454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Restriction analysis of genome composition of live influenza vaccine].
    Kiseleva IV; Larionova NV; Teley LC; Rudenko LG
    Vopr Virusol; 2011; 56(3):28-32. PubMed ID: 21786624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.
    Treanor JJ; Betts RF
    Vaccine; 1998 Nov; 16(18):1756-60. PubMed ID: 9778752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
    Wohlgemuth N; Ye Y; Fenstermacher KJ; Liu H; Lane AP; Pekosz A
    Vaccine; 2017 Dec; 35(48 Pt B):6691-6699. PubMed ID: 29079099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Cho I; Reisinger K; Block SL; Wittes J; Iacuzio D; Piedra P; Treanor J; King J; Kotloff K; Bernstein DI; Hayden FG; Zangwill K; Yan L; Wolff M
    J Pediatr; 2000 Feb; 136(2):168-75. PubMed ID: 10657821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.
    Chen H; Matsuoka Y; Swayne D; Chen Q; Cox NJ; Murphy BR; Subbarao K
    Vaccine; 2003 Oct; 21(27-30):4430-6. PubMed ID: 14505926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.
    Murphy BR; Holley HP; Berquist EJ; Levine MM; Spring SB; Maassab HF; Kendal AP; Chanock RM
    Infect Immun; 1979 Feb; 23(2):253-9. PubMed ID: 422240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.